Biopharmaceuticals
FDA
HIV/AIDS
News Release - January 21, 2008
FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy
Source: Tibotec Therapeutics
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.